Boral Anthony L.

Avg. Two Year Performance

No purchase track record
(9%) Avg. Sale Return
(5%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(8%)(11%)(12%)(5%)(9%)
Sale Success Rate3 of 94 of 93 of 93 of 90 of 9

Blueprint Medicines Corp

Drugs » Biotechnology

Chief Medical Officer:

Holdings: 28.15K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--